Pfizer files for FDA approval on coronavirus vaccine for ages 5-11

Published



Pfizer filed an application with the Food and Drug Administration on Thursday seeking emergency use authorization for its coronavirus vaccine that is approved for distribution among children age 5-11.

The FDA said it would look over the application and decide in a matter of weeks, rather than the months these types of applications normally take.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.